Received: 12 April 2022
Accepted: 25 November 2022
First Online: 3 December 2022
: Permission was obtained from the Ministry of Health (MOH) and administrative clearance sought from District Health Officers to conduct this evaluation. The Office of Science, US Centers for Disease Control and Prevention, determined that the primary intent of this evaluation was public health practice. It was determined therefore to not be human subject research. Verbal consent was sought from all respondents before data collection. Written informed consent was not obtained to minimize the risk of spreading COVID-19 infection, since MoH Standard Operating Procedures (SOPs) discouraged exchange of materials by hand. Participants were told that their participation was voluntary and that there would be no negative consequences if they refused to participate. During data collection, respondents were assigned unique identifiers instead of names to protect their confidentiality. Information was stored in password-protected computers and was not shared with anyone outside the investigation team.
: Not applicable.
: The authors declare that they have no competing interests.